E1	Procedure:T1 Name:T2 Temporality:E2 Temporality2:E4
E3	Condition:T3 Name:T4
E5	Observation:T5 Name:T6 Eq-Comparison:E42
E7	Observation:T7 Name:T8 Eq-Comparison:E43 Eq-Comparison2:E44
E9	Observation:T9 Name:T10 Eq-Comparison:E45 Eq-Comparison2:E46
E11	Observation:T11 Name:T12 Eq-Comparison:E47 Eq-Comparison2:E48
E13	Procedure:T13 Name:T14
E15	Procedure:T15 Name:T16
E19	Condition:T19 Name:T20
E23	Condition:T23 Name:T24
E25	Condition:T25 Name:T26
E27	Condition:T27 Name:T28
E29	Condition:T29 Name:T30
E31	Condition:T31 Name:T32 Temporality:E102
E37	Condition:T37 Name:T38
E39	Condition:T39 Name:T40
E41	Condition:T41 Name:T42
E42	Eq-Comparison:T90 Operator:T44 Value:T72 Unit:T114
E43	Eq-Comparison:T91 Operator:T45 Value:T73 Unit:T119
E44	Eq-Comparison:T92 Operator:T46 Value:T74 Unit:T121
E45	Eq-Comparison:T93 Operator:T47 Value:T75 Unit:T130
E46	Eq-Comparison:T94 Operator:T48 Value:T76 Unit:T132
E47	Eq-Comparison:T95 Operator:T49 Value:T77 Unit:T141
E48	Eq-Comparison:T96 Operator:T50 Value:T78 Unit:T142
E49	Eq-Comparison:T97 Operator:T51 Value:T79 Unit:T148 Per:T63
E50	Eq-Comparison:T98 Operator:T52 Value:T80 Unit:T151 Per:T64
E51	Eq-Comparison:T99 Operator:T53 Value:T81 Unit:T158 Per:T65
E52	Eq-Comparison:T100 Operator:T54 Value:T82 Unit:T160 Per:T66
E53	Eq-Comparison:T101 Operator:T55 Value:T83 Unit:T168 Per:T67
E54	Eq-Comparison:T102 Operator:T56 Value:T84 Unit:T170 Per:T68
E55	Eq-Comparison:T103 Operator:T57 Value:T85 Unit:T179 Per:T180 Per2:T181
E56	Eq-Comparison:T104 Operator:T58 Value:T86 Unit:T182 Per:T183
E57	Eq-Comparison:T105 Operator:T59 Temporal-Unit:T61 Value:T87
E58	Eq-Comparison:T106 Operator:T60 Temporal-Unit:T62 Value:T89
E2	Eq-Comparison:T107 Temporal-Period:T108
E4	Eq-Comparison:T109 Operator:T110 Value:T70 Value2:T71
E6	Eq-Comparison:T111 Value:T112
E8	Criteria-Count:T113 Min-Value:E6 Criteria:E5 Criteria3:E22 Criteria2:E12 Criteria4:E36 Criteria5:E63 Criteria6:E69 Criteria7:E75 Criteria8:E81
E10	Modifier:T115 Modifies:E42
E12	Drug:T116 Name:T117
E14	And:T118 Arg:E12 Arg2:E7
E16	Modifier:T120 Modifies:E43
E18	Or:T122 Arg:E43 Arg2:E44
E20	Modifier:T123 Modifies:E44
E22	Drug:T124 Name:T125
E24	Drug:T126 Name:T127
E26	And:T128 Arg:E22 Arg2:E24
E28	And:T129 Arg:E24 Arg2:E9
E30	Modifier:T131 Modifies:E45
E32	Modifier:T133 Modifies:E46
E34	Or:T134 Arg:E45 Arg2:E46
E36	Drug:T135 Name:T136
E38	Drug:T137 Name:T138
E40	And:T139 Arg:E36 Arg2:E38
E59	And:T140 Arg:E38 Arg2:E11
E60	Modifier:T143 Modifies:E47
E61	Modifier:T144 Modifies:E48
E62	Or:T145 Arg:E47 Arg2:E48
E63	Drug:T146 Name:T147 Dose:E49 Dose2:E50
E64	Modifier:T149 Modifies:E49
E65	Modifier:T150 Modifies:E50
E66	Or:T152 Arg:E49 Arg2:E50
E67	Drug:T153 Name:T154
E68	And:T155 Arg:E63 Arg2:E67
E69	Drug:T156 Name:T157 Dose:E51 Dose2:E52
E70	Modifier:T159 Modifies:E51
E71	Or:T161 Arg:E51 Arg2:E52
E72	Modifier:T162 Modifies:E52
E73	Drug:T163 Name:T164
E74	And:T165 Arg:E69 Arg2:E73
E75	Drug:T166 Name:T167 Dose:E53 Dose2:E54
E76	Modifier:T169 Modifies:E53
E77	Modifier:T171 Modifies:E54
E78	Or:T172 Arg:E53 Arg2:E54
E79	Drug:T173 Name:T174
E80	And:T175 Arg:E75 Arg2:E79
E81	Drug:T69 Name:T176
E82	Observation:T177 Name:T178 Eq-Comparison:E55 Eq-Comparison2:E56
E83	Or:T184 Arg:E55 Arg2:E56
E84	Or:T185 Arg:E8 Arg2:E13
E17	Drug:T17 Name:T18
E85	Drug:T186 Name:T187
E86	Or:T188 Arg:E17 Arg2:E85
E87	Risk:T189 Polarity:T21 Risk-For:E37
E21	Or:T22 Arg:E13 Arg2:E87
E88	Condition:T190 Name:T191
E33	Procedure:T33 
E35	Drug:T34 Name:T35 Temporality:E57
E89	Drug:T36 Name:T88 Temporality:E57
E90	Or:T192 Arg:E35 Arg2:E89
E91	Encounter:T193 Type:T194
E92	Procedure:T195 Name:T196
E93	Temporal-Connection:T197 Arg:E57 Arg2:E91
E94	Eq-Comparison:T198 Value:T199
E95	Procedure:T200 Name:T201 Minimum-Count:E94 Temporality:E58
E96	Modifier:T202 Modifies:T201
E97	Coreference:T203 Refers-To:E95
E98	Temporal-Connection:T204 Arg:E58 Arg2:E97
E99	Modifier:T205 Modifies:T32
E100	Modifier:T206 Modifies:T32
E101	Or:T207 Arg:E100 Arg2:E99
E102	Eq-Comparison:T208 Temporal-Period:T209
E103	Condition:T210 
E104	Other:T211 Is-Other:E103
E105	Or:T212 Arg:E31 Arg2:E103
E106	Risk:T213 Polarity:T214 Risk-For:E41 Stability:T215
E107	Procedure:T43 Name:T216
E108	Contraindication:T217 Contraindicates:E107
E109	Condition:T218 Name:T219
E110	Assertion:T220 Asserted:E41
T1	Procedure 50 76	myeloablative conditioning
T2	Procedure-Name 50 76	myeloablative conditioning
T3	Condition 89 92	HCT
T4	Condition-Name 89 92	HCT
T5	Observation 168 171	TBI
T6	Observation-Name 168 171	TBI
T7	Observation 228 231	TBI
T8	Observation-Name 228 231	TBI
T9	Observation 321 324	TBI
T10	Observation-Name 321 324	TBI
T11	Observation 414 417	TBI
T12	Observation-Name 414 417	TBI
T13	Procedure 906 932	myeloablative conditioning
T14	Procedure-Name 906 932	myeloablative conditioning
T15	Procedure 1025 1036	prophylaxis
T16	Procedure-Name 1025 1036	prophylaxis
T19	Condition 1020 1024	GVHD
T20	Condition-Name 1020 1024	GVHD
T23	Condition 1325 1340	steatohepatitis
T24	Condition-Name 1325 1340	steatohepatitis
T25	Condition 1139 1152	Osteopetrosis
T26	Condition-Name 1139 1152	Osteopetrosis
T27	Condition 1310 1323	iron overload
T28	Condition-Name 1310 1323	iron overload
T29	Condition 1154 1165	Thalassemia
T30	Condition-Name 1154 1165	Thalassemia
T31	Condition 1375 1384	hepatitis
T32	Condition-Name 1375 1384	hepatitis
T37	Condition 1077 1080	SOS
T38	Condition-Name 1077 1080	SOS
T39	Condition 1134 1137	HLH
T40	Condition-Name 1134 1137	HLH
T41	Condition 1462 1465	SOS
T42	Condition-Name 1462 1465	SOS
T44	Eq-Operator 172 174	>=
T45	Eq-Operator 233 234	>
T46	Eq-Operator 255 256	>
T47	Eq-Operator 326 327	>
T48	Eq-Operator 348 349	>
T49	Eq-Operator 419 420	>
T50	Eq-Operator 441 442	>
T51	Eq-Operator 498 499	>
T52	Eq-Operator 516 517	>
T53	Eq-Operator 584 585	>
T54	Eq-Operator 601 602	>
T55	Eq-Operator 663 664	>
T56	Eq-Operator 680 681	>
T57	Eq-Operator 760 761	>
T58	Eq-Operator 781 782	>
T59	Eq-Operator 1207 1213	within
T60	Eq-Operator 1284 1290	within
T61	Eq-Temporal-Unit 1216 1222	months
T62	Eq-Temporal-Unit 1293 1299	months
T63	Eq-Unit 507 509	kg
T64	Eq-Unit 523 525	kg
T65	Eq-Unit 592 594	kg
T66	Eq-Unit 609 611	kg
T67	Eq-Unit 671 673	kg
T68	Eq-Unit 688 690	kg
T70	Eq-Value 101 109	4/1/2019
T71	Eq-Value 114 124	12/31/2120
T72	Eq-Value 175 179	1200
T73	Eq-Value 235 238	500
T74	Eq-Value 257 260	800
T75	Eq-Value 328 331	500
T76	Eq-Value 350 353	800
T77	Eq-Value 421 424	500
T78	Eq-Value 443 446	800
T79	Eq-Value 500 503	7.2
T80	Eq-Value 517 520	9.0
T81	Eq-Value 585 588	7.2
T82	Eq-Value 602 605	9.0
T83	Eq-Value 664 667	7.2
T84	Eq-Value 681 684	9.0
T85	Eq-Value 761 763	75
T86	Eq-Value 782 787	18270
T87	Eq-Value 1214 1215	3
T89	Eq-Value 1291 1292	6
T90	Eq-Comparison 172 183	>= 1200 cGy
T91	Eq-Comparison 233 242	> 500 cGy
T92	Eq-Comparison 255 263	> 800cGy
T93	Eq-Comparison 326 335	> 500 cGy
T94	Eq-Comparison 348 357	> 800 cGy
T95	Eq-Comparison 419 428	> 500 cGy
T96	Eq-Comparison 441 450	> 800 cGy
T97	Eq-Comparison 498 509	> 7.2 mg/kg
T98	Eq-Comparison 516 525	>9.0mg/kg
T99	Eq-Comparison 584 594	>7.2 mg/kg
T100	Eq-Comparison 601 611	>9.0 mg/kg
T101	Eq-Comparison 663 673	>7.2 mg/kg
T102	Eq-Comparison 680 690	>9.0 mg/kg
T103	Eq-Comparison 760 777	>75 mg/L per hour
T104	Eq-Comparison 781 809	>18270 microMolar per minute
T105	Eq-Comparison 1207 1222	within 3 months
T106	Eq-Comparison 1284 1299	within 6 months
T107	Eq-Comparison 37 47	undergoing
T108	Eq-Temporal-Period 37 47	undergoing
T109	Eq-Comparison 93 124	between 4/1/2019 and 12/31/2120
T110	Eq-Operator 93 100	between
T111	Eq-Comparison 136 139	one
T112	Eq-Value 136 139	one
T113	Criteria-Count 143 156	the following
T114	Eq-Unit 180 183	cGy
T115	Modifier 185 197	fractionated
T116	Drug 209 225	Cyclophosphamide
T117	Drug-Name 209 225	Cyclophosphamide
T118	And 226 227	+
T119	Eq-Unit 239 242	cGy
T120	Modifier 244 250	single
T121	Eq-Unit 260 263	cGy
T122	Or 252 254	or
T123	Modifier 265 277	fractionated
T124	Drug 290 306	Cyclophosphamide
T125	Drug-Name 290 306	Cyclophosphamide
T126	Drug 309 318	Etoposide
T127	Drug-Name 309 318	Etoposide
T128	And 307 308	+
T129	And 319 320	+
T130	Eq-Unit 332 335	cGy
T131	Modifier 337 343	single
T132	Eq-Unit 354 357	cGy
T133	Modifier 359 371	fractionated
T134	Or 345 347	or
T135	Drug 384 400	Cyclophosphamide
T136	Drug-Name 384 400	Cyclophosphamide
T137	Drug 403 411	Thiotepa
T138	Drug-Name 403 411	Thiotepa
T139	And 401 402	+
T140	And 412 413	+
T141	Eq-Unit 425 428	cGy
T142	Eq-Unit 447 450	cGy
T143	Modifier 430 436	single
T144	Modifier 452 464	fractionated
T145	Or 438 440	or
T146	Drug 477 485	Busulfan
T147	Drug-Name 477 485	Busulfan
T148	Eq-Unit 504 506	mg
T149	Modifier 510 512	IV
T150	Modifier 526 532	orally
T151	Eq-Unit 520 522	mg
T152	Or 513 515	or
T153	Drug 536 552	Cyclophosphamide
T154	Drug-Name 536 552	Cyclophosphamide
T155	And 534 535	+
T156	Drug 563 571	Busulfan
T157	Drug-Name 563 571	Busulfan
T158	Eq-Unit 589 591	mg
T159	Modifier 595 597	IV
T160	Eq-Unit 606 608	mg
T161	Or 598 600	or
T162	Modifier 612 618	orally
T163	Drug 622 631	Melphalan
T164	Drug-Name 622 631	Melphalan
T165	And 620 621	+
T166	Drug 642 650	Busulfan
T167	Drug-Name 642 650	Busulfan
T168	Eq-Unit 668 670	mg
T169	Modifier 674 676	IV
T170	Eq-Unit 685 687	mg
T171	Modifier 691 697	orally
T172	Or 677 679	or
T173	Drug 701 709	Thiotepa
T174	Drug-Name 701 709	Thiotepa
T175	And 699 700	+
T69	Drug 726 734	Busulfan
T176	Drug-Name 726 734	Busulfan
T177	Observation 735 756	cumulative plasma AUC
T178	Observation-Name 735 756	cumulative plasma AUC
T179	Eq-Unit 764 766	mg
T180	Eq-Unit 767 768	L
T181	Eq-Temporal-Unit 773 777	hour
T182	Eq-Unit 788 798	microMolar
T183	Eq-Temporal-Unit 803 809	minute
T184	Or 778 780	or
T185	Or 878 880	OR
T17	Drug 991 1000	sirolimus
T18	Drug-Name 991 1000	sirolimus
T186	Drug 1005 1015	tacrolimus
T187	Drug-Name 1005 1015	tacrolimus
T188	Or 1001 1004	and
T189	Risk 1068 1072	risk
T21	Polarity 1063 1067	high
T22	Or 1038 1040	OR
T190	Condition 1119 1132	Neuroblastoma
T191	Condition-Name 1119 1132	Neuroblastoma
T33	Procedure 1167 1176	treatment
T34	Drug 1182 1192	inotuzumab
T35	Drug-Name 1182 1192	inotuzumab
T36	Drug 1196 1206	gemtuzumab
T88	Drug-Name 1196 1206	gemtuzumab
T192	Or 1193 1195	or
T193	Encounter 1237 1246	admission
T194	Encounter-Type 1237 1246	admission
T195	Procedure 1232 1236	HSCT
T196	Procedure-Name 1232 1236	HSCT
T197	Temporal-Connection 1223 1231	prior to
T198	Eq-Comparison 1248 1251	2nd
T199	Eq-Value 1248 1251	2nd
T200	Procedure 1252 1256	HSCT
T201	Procedure-Name 1252 1256	HSCT
T202	Modifier 1266 1279	myeloablative
T203	Coreference 1303 1308	prior
T204	Temporal-Connection 1300 1302	of
T205	Modifier 1365 1374	infection
T206	Modifier 1349 1361	inflammatory
T207	Or 1362 1364	or
T208	Eq-Comparison 1342 1348	active
T209	Eq-Temporal-Period 1342 1348	active
T210	Condition 1398 1407	condition
T211	Other 1392 1397	other
T212	Or 1385 1387	or
T213	Risk 1443 1447	risk
T214	Polarity 1436 1442	higher
T215	Stability 1414 1418	puts
T43	Procedure 1532 1538	US SWE
T216	Procedure-Name 1532 1538	US SWE
T217	Contraindication 1512 1528	contraindication
T218	Condition 1545 1565	unable to hold still
T219	Condition-Name 1545 1565	unable to hold still
T220	Assertion 1451 1461	developing
A1	Eq-Operator-Value T44 GTEQ
A2	Eq-Operator-Value T45 GT
A3	Eq-Operator-Value T46 GT
A4	Eq-Operator-Value T47 GT
A5	Eq-Operator-Value T48 GT
A6	Eq-Operator-Value T49 GT
A7	Eq-Operator-Value T50 GT
A8	Eq-Operator-Value T51 GT
A9	Eq-Operator-Value T52 GT
A10	Eq-Operator-Value T53 GT
A11	Eq-Operator-Value T54 GT
A12	Eq-Operator-Value T55 GT
A13	Eq-Operator-Value T56 GT
A14	Eq-Operator-Value T57 GT
A15	Eq-Operator-Value T58 GT
A16	Eq-Operator-Value T59 LTEQ
A17	Eq-Operator-Value T60 LTEQ
A18	Eq-Temporal-Unit-Value T61 month
A19	Eq-Temporal-Unit-Value T62 month
A20	Eq-Temporal-Period-Value T108 present
A21	Eq-Operator-Value T110 BETWEEN
A22	Observation-Type-Value T6 lab
A23	Observation-Type-Value T8 lab
A24	Observation-Type-Value T10 lab
A25	Observation-Type-Value T12 lab
A26	Observation-Type-Value T178 lab
A27	Eq-Temporal-Unit-Value T181 hour
A28	Eq-Temporal-Unit-Value T183 minute
A29	Polarity-Value T21 high
A30	Encounter-Type-Value T194 inpatient
A31	Temporal-Connection-Type-Value E93 before
A32	Temporal-Connection-Type-Value E98 before
A33	Eq-Temporal-Period-Value T209 present
A34	Polarity-Value T214 high
A35	Stability-Value T215 change
A36	Assertion-Type-Value E110 hypothetical
R1	Treatment-For Arg1:E1 Arg2:E3
R2	Equivalent-To Arg1:E8 Arg2:E1
R3	Treatment-For Arg1:E15 Arg2:E19
R4	Using Arg1:E15 Arg2:E85
R5	Using Arg1:E15 Arg2:E17
R6	Using Arg1:E13 Arg2:E15
R7	Using Arg1:E33 Arg2:E35
R8	Using Arg1:E91 Arg2:E92
R9	Caused-By Arg1:T215 Arg2:E103
R10	Example-Of Arg1:E109 Arg2:E108
R11	Using Arg1:E33 Arg2:E89
